<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34322715</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>17-18</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers.</ArticleTitle><Pagination><StartPage>6143</StartPage><EndPage>6160</EndPage><MedlinePgn>6143-6160</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-021-03905-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rare, devastating disease, causing movement impairment, respiratory failure and ultimate death. A plethora of genetic, cellular and molecular mechanisms are involved in ALS signature, although the initiating causes and progressive pathological events are far from being understood. Drosophila research has produced seminal discoveries for more than a century and has been successfully used in the past 25&#xa0;years to untangle the process of ALS pathogenesis, and recognize potential markers and novel strategies for therapeutic solutions. This review will provide an updated view of several ALS modifiers validated in C9ORF72, SOD1, FUS, TDP-43 and Ataxin-2 Drosophila models. We will discuss basic and preclinical findings, illustrating recent developments and novel breakthroughs, also depicting unsettled challenges and limitations in the Drosophila-ALS field. We intend to stimulate a renewed debate on Drosophila as a screening route to identify more successful disease modifiers and neuroprotective agents.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liguori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3456-6574</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 65, 00143, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadio</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9266-4597</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 65, 00143, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volont&#xe9;</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7362-8307</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 65, 00143, Rome, Italy. cinzia.volonte@cnr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Analysis and Computer Science "A. Ruberti", National Research Council (IASI-CNR), Via dei Taurini 19, 00185, Rome, Italy. cinzia.volonte@cnr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067698">Ataxin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067698" MajorTopicYN="N">Ataxin-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Experimental animal models</Keyword><Keyword MajorTopicYN="N">Genetic modifiers</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34322715</ArticleId><ArticleId IdType="doi">10.1007/s00018-021-03905-8</ArticleId><ArticleId IdType="pii">10.1007/s00018-021-03905-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trojsi F, D&#x2019;Alvano G, Bonavita S, Tedeschi G (2020) Genetics and sex in the pathogenesis of amyotrophic lateral sclerosis (ALS): is there a link? Int J Mol Sci. https://doi.org/10.3390/ijms21103647</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103647</ArticleId><ArticleId IdType="pubmed">32455692</ArticleId><ArticleId IdType="pmc">7279172</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR, Kirby J (2016) The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis 6:49&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">30050368</ArticleId><ArticleId IdType="pmc">6053097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34:404&#x2013;423</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pmc">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. https://doi.org/10.1111/ene.14393</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId><ArticleId IdType="pmc">7540334</ArticleId></ArticleIdList></Reference><Reference><Citation>Liscic RM, Alberici A, Cairns NJ, Romano M, Buratti E (2020) From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline. Mol Neurodegener 15:31</Citation><ArticleIdList><ArticleId IdType="pubmed">32487123</ArticleId><ArticleId IdType="pmc">7268618</ArticleId><ArticleId IdType="doi">10.1186/s13024-020-00373-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram S, Loeb JA, Song F (2020) Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment. J Neuroinflammation 17:175</Citation><ArticleIdList><ArticleId IdType="pubmed">32505190</ArticleId><ArticleId IdType="pmc">7276078</ArticleId><ArticleId IdType="doi">10.1186/s12974-020-01849-7</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Berson A, Bonini NM (2015) Drosophila as an in vivo model for human neurodegenerative disease. Genetics 201:377&#x2013;402</Citation><ArticleIdList><ArticleId IdType="pubmed">26447127</ArticleId><ArticleId IdType="pmc">4596656</ArticleId><ArticleId IdType="doi">10.1534/genetics.115.179457</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter LT, Potocki L, Chien S, Gribskov M, Bier E (2001) A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11:1114&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="pubmed">11381037</ArticleId><ArticleId IdType="pmc">311089</ArticleId><ArticleId IdType="doi">10.1101/gr.169101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M, Yoshida H (2018) Drosophila as a model organism. Adv Exp Med Biol 1076:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">29951811</ArticleId><ArticleId IdType="doi">10.1007/978-981-13-0529-0_1</ArticleId><ArticleId IdType="pmc">29951811</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori F, Amadio S, Volont&#xe9; C (2021) Where and why modeling amyotrophic lateral sclerosis. Int J Mol Sci 22(8):3977&#xa0;</Citation><ArticleIdList><ArticleId IdType="pubmed">33921446</ArticleId><ArticleId IdType="pmc">8070525</ArticleId><ArticleId IdType="doi">10.3390/ijms22083977</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32:771&#x2013;776</Citation><ArticleIdList><ArticleId IdType="pubmed">31361627</ArticleId><ArticleId IdType="pmc">6735526</ArticleId><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688&#x2013;1700</Citation><ArticleIdList><ArticleId IdType="pubmed">11386269</ArticleId><ArticleId IdType="pmc">11386269</ArticleId><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10:661&#x2013;670</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pmc">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DA, Mitchell JC, Salcher-Konrad MT, Vance CA, Mizielinska S (2019) Review: modelling the pathology and behaviour of frontotemporal dementia. Neuropathol Appl Neurobiol 45:58&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">30582188</ArticleId><ArticleId IdType="doi">10.1111/nan.12536</ArticleId><ArticleId IdType="pmc">30582188</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, Chia R (2020) The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 14:42</Citation><ArticleIdList><ArticleId IdType="pubmed">32116499</ArticleId><ArticleId IdType="pmc">7012787</ArticleId><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;gal L, Vanopdenbosch L, Tilkin P et al (2006) The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. Arch Neurol 63:262&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pubmed">16476815</ArticleId><ArticleId IdType="doi">10.1001/archneur.63.2.262</ArticleId><ArticleId IdType="pmc">16476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Kitagawa K, Arai K (2020) Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology 40:40&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pubmed">31802540</ArticleId><ArticleId IdType="doi">10.1111/neup.12606</ArticleId><ArticleId IdType="pmc">31802540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Thonhoff JR et al (2020) Immunosuppressive functions of M2 macrophages derived from iPSCs of patients with ALS and healthy controls. iScience 23(6):101192</Citation><ArticleIdList><ArticleId IdType="pubmed">32521508</ArticleId><ArticleId IdType="pmc">7286967</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2020.101192</ArticleId></ArticleIdList></Reference><Reference><Citation>Osking Z, Ayers JI, Hildebrandt R et al (2019) ALS-linked SOD1 mutants enhance neurite outgrowth and branching in adult motor neurons. iScience 19:448&#x2013;449</Citation><ArticleIdList><ArticleId IdType="pubmed">31425915</ArticleId><ArticleId IdType="pmc">6708981</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2019.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Giacovazzo G et al (2020) Skeletal-muscle metabolic reprogramming in ALS-SOD1. iScience 23:101087</Citation><ArticleIdList><ArticleId IdType="pubmed">32371370</ArticleId><ArticleId IdType="pmc">7200935</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2020.101087</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18:211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">30663610</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pmc">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C (2019) Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve 59:10&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">29979464</ArticleId><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pmc">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser KJ, Smith C, Herman FJ, Ono K, Pasinetti GM (2019) Mechanisms of immune activation by. Front Neurosci 13:1298</Citation><ArticleIdList><ArticleId IdType="pubmed">31920478</ArticleId><ArticleId IdType="pmc">6914852</ArticleId><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, Amadio S, Fabbrizio P et al (2019) Histaminergic transmission slows progression of amyotrophic lateral sclerosis. J Cachexia Sarcopenia Muscle 10:872&#x2013;893</Citation><ArticleIdList><ArticleId IdType="pubmed">31020811</ArticleId><ArticleId IdType="pmc">6711424</ArticleId><ArticleId IdType="doi">10.1002/jcsm.12422</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C, Apolloni S, Sabatelli M (2019) Histamine beyond its effects on allergy: potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS). Pharmacol Ther 202:120&#x2013;131</Citation><ArticleIdList><ArticleId IdType="pubmed">31233766</ArticleId><ArticleId IdType="doi">10.1016/j.pharmthera.2019.06.006</ArticleId><ArticleId IdType="pmc">31233766</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M, Omori K, Asada S, Yoshida H (2021) Epigenetic regulation of ALS and CMT: a lesson from Drosophila Models. Int J Mol Sci 22(2):491</Citation><ArticleIdList><ArticleId IdType="pmc">7825332</ArticleId><ArticleId IdType="doi">10.3390/ijms22020491</ArticleId></ArticleIdList></Reference><Reference><Citation>Layalle S, They L, Ourghani S, Raoul C, Soustelle L (2021) Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster. Int J Mol Sci 22(2):904</Citation><ArticleIdList><ArticleId IdType="pmc">7831090</ArticleId><ArticleId IdType="doi">10.3390/ijms22020904</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y, Mizuta I, Tokuda T, Mizuno T (2018) Amyotrophic lateral sclerosis model. Adv Exp Med Biol 1076:79&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pubmed">29951816</ArticleId><ArticleId IdType="doi">10.1007/978-981-13-0529-0_6</ArticleId><ArticleId IdType="pmc">29951816</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M, Bellen HJ (2018) Genetic strategies to tackle neurological diseases in fruit flies. Curr Opin Neurobiol 50:24&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">29128849</ArticleId><ArticleId IdType="doi">10.1016/j.conb.2017.10.017</ArticleId><ArticleId IdType="pmc">29128849</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401&#x2013;415</Citation><ArticleIdList><ArticleId IdType="pubmed">8223268</ArticleId><ArticleId IdType="doi">10.1242/dev.118.2.401</ArticleId><ArticleId IdType="pmc">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire SE, Mao Z, Davis RL (2004) Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci STKE 2004(220):pl6</Citation><ArticleIdList><ArticleId IdType="pubmed">14970377</ArticleId><ArticleId IdType="pmc">14970377</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer J, Wang Q, Le T, et al. (2016) Quantitative Assessment of Eye Phenotypes for Functional Genetic Studies Using Drosophila melanogaster. G3 (Bethesda) 6:1427&#x2013;1437</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.116.027060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ready DF, Hanson TE, Benzer S (1976) Development of the Drosophila retina, a neurocrystalline lattice. Dev Biol 53:217&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">825400</ArticleId><ArticleId IdType="doi">10.1016/0012-1606(76)90225-6</ArticleId><ArticleId IdType="pmc">825400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar JP (2012) Building an ommatidium one cell at a time. Dev Dyn 241:136&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">22174084</ArticleId><ArticleId IdType="pmc">3427658</ArticleId><ArticleId IdType="doi">10.1002/dvdy.23707</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Pandey UB (2015) A fruitful endeavor: modeling ALS in the fruit fly. Brain Res 1607:47&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">25289585</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2014.09.064</ArticleId><ArticleId IdType="pmc">25289585</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal N, Jaiswal M (2018) Pathways to neurodegeneration: lessons learnt from unbiased genetic screens in. J Genet 97:773&#x2013;781</Citation><ArticleIdList><ArticleId IdType="pubmed">30027908</ArticleId><ArticleId IdType="doi">10.1007/s12041-018-0954-4</ArticleId><ArticleId IdType="pmc">30027908</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323&#x2013;330</Citation><ArticleIdList><ArticleId IdType="pubmed">22406228</ArticleId><ArticleId IdType="pmc">3322422</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard SR, Parker MD, Cooper-Knock J et al (2021) Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2020-325014</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId><ArticleId IdType="pmc">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Campanari ML, Julie Corbier C et al (2016) Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J 35:1276&#x2013;1297</Citation><ArticleIdList><ArticleId IdType="pubmed">27103069</ArticleId><ArticleId IdType="pmc">4910533</ArticleId><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W, Hu F (2020) Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. J Neurochem. https://doi.org/10.1111/jnc.15255</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId><ArticleId IdType="pmc">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Newhouse S, Shatunov A et al (2013) The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet 21:102&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pubmed">22692064</ArticleId><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J, Poulter M, Hensman D et al (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 92:345&#x2013;353</Citation><ArticleIdList><ArticleId IdType="pubmed">23434116</ArticleId><ArticleId IdType="pmc">3591848</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2013.01.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Poidevin M, Li X et al (2013) Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci USA 110:7778&#x2013;7783</Citation><ArticleIdList><ArticleId IdType="pubmed">23553836</ArticleId><ArticleId IdType="pmc">23553836</ArticleId><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gr&#xf6;nke S, Niccoli T et al (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345:1192&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pubmed">25103406</ArticleId><ArticleId IdType="pmc">4944841</ArticleId><ArticleId IdType="doi">10.1126/science.1256800</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R et al (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525:129&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">26308899</ArticleId><ArticleId IdType="pmc">4631399</ArticleId><ArticleId IdType="doi">10.1038/nature14974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Carlomagno Y, Zhang YJ et al (2016) Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science 353:708&#x2013;712</Citation><ArticleIdList><ArticleId IdType="pubmed">27516603</ArticleId><ArticleId IdType="pmc">5823025</ArticleId><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ et al (2016) C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167:774-788.e717</Citation><ArticleIdList><ArticleId IdType="pubmed">5079111</ArticleId><ArticleId IdType="pmc">5079111</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S, van der Zee J, Cruts M, Van Broeckhoven C (2017) Relationship between C9orf72 repeat size and clinical phenotype. Curr Opin Genet Dev 44:117&#x2013;124</Citation><ArticleIdList><ArticleId IdType="pubmed">28319737</ArticleId><ArticleId IdType="doi">10.1016/j.gde.2017.02.008</ArticleId><ArticleId IdType="pmc">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Kramer NJ et al (2019) Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat Neurosci 22:863&#x2013;874</Citation><ArticleIdList><ArticleId IdType="pubmed">31110321</ArticleId><ArticleId IdType="pmc">6535128</ArticleId><ArticleId IdType="doi">10.1038/s41593-019-0396-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Toro A, Sahana TG et al (2020) Divergence, convergence, and therapeutic implications: a cell biology perspective of C9ORF72-ALS/FTD. Mol Neurodegener 15(1):34&#xa0;</Citation><ArticleIdList><ArticleId IdType="pubmed">32513219</ArticleId><ArticleId IdType="pmc">7282082</ArticleId><ArticleId IdType="doi">10.1186/s13024-020-00383-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Gibbens B, Doty NS et al (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 108:260&#x2013;265</Citation><ArticleIdList><ArticleId IdType="pubmed">21173221</ArticleId><ArticleId IdType="doi">10.1073/pnas.1013343108</ArticleId><ArticleId IdType="pmc">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77:639&#x2013;646</Citation><ArticleIdList><ArticleId IdType="pubmed">23415312</ArticleId><ArticleId IdType="pmc">3593233</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T et al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339:1335&#x2013;1338</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pmc">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Belzil VV, Zhang YJ, Petrucelli L (2014) Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol 127:359&#x2013;376</Citation><ArticleIdList><ArticleId IdType="pubmed">24394885</ArticleId><ArticleId IdType="pmc">4002260</ArticleId><ArticleId IdType="doi">10.1007/s00401-013-1237-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, B&#xe4;umer D, East S et al (2014) Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging 35:1779.e1775-1779.e1713</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang JY et al (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaf6038</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId><ArticleId IdType="pmc">5024536</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S, Acharya KR, Subramanian V (2018) A comparative bioinformatic analysis of. PeerJ. https://doi.org/10.7717/peerj.4391</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.4391</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId><ArticleId IdType="pmc">6195791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall AC, Ostrowski LA, Pietrobon V, Mekhail K (2017) Repetitive DNA loci and their modulation by the non-canonical nucleic acid structures R-loops and G-quadruplexes. Nucleus 8:162&#x2013;181</Citation><ArticleIdList><ArticleId IdType="pubmed">28406751</ArticleId><ArticleId IdType="pmc">5403138</ArticleId><ArticleId IdType="doi">10.1080/19491034.2017.1292193</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Bonini NM (2020) New roles for canonical transcription factors in repeat expansion diseases. Trends Genet 36:81&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">31837826</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pmc">31837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirtreiter A, Damsma GE, Cheung AC et al (2010) Spt4/5 stimulates transcription elongation through the RNA polymerase clamp coiled-coil motif. Nucleic Acids Res 38:4040&#x2013;4051</Citation><ArticleIdList><ArticleId IdType="pubmed">20197319</ArticleId><ArticleId IdType="pmc">2896526</ArticleId><ArticleId IdType="doi">10.1093/nar/gkq135</ArticleId></ArticleIdList></Reference><Reference><Citation>Celona B, Dollen JV, Vatsavayai SC et al (2017) Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. Elife. https://doi.org/10.7554/eLife.19032</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19032</ArticleId><ArticleId IdType="pubmed">28072389</ArticleId><ArticleId IdType="pmc">5283830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Daley EL, Gleixner AM et al (2020) RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by matrin-3. Acta Neuropathol Commun 8:177</Citation><ArticleIdList><ArticleId IdType="pubmed">33129345</ArticleId><ArticleId IdType="pmc">7603783</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01060-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao B, Wang M, Feng H et al (2021) Downregulation of TOP2 modulates neurodegeneration caused by GGGGCC expanded repeats. Hum Mol Genet. https://doi.org/10.1093/hmg/ddab079</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab079</ArticleId><ArticleId IdType="pubmed">33749734</ArticleId><ArticleId IdType="pmc">33749734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Gr&#xe4;sser FA et al (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 126:881&#x2013;893</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pmc">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Srinivasan AR et al (2019) eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol Commun 7:62</Citation><ArticleIdList><ArticleId IdType="pubmed">31023341</ArticleId><ArticleId IdType="pmc">6485101</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0711-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T et al (2014) Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84:1213&#x2013;1225</Citation><ArticleIdList><ArticleId IdType="pubmed">25521377</ArticleId><ArticleId IdType="pmc">4632245</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Abdallah A, Li Z, Lu Y, Almeida S, Gao FB (2015) FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol 130:525&#x2013;535</Citation><ArticleIdList><ArticleId IdType="pubmed">26031661</ArticleId><ArticleId IdType="pmc">4575383</ArticleId><ArticleId IdType="doi">10.1007/s00401-015-1448-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S, Han Y, Das A, Dickman D (2017) Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration. Hum Mol Genet 26:4153&#x2013;4167</Citation><ArticleIdList><ArticleId IdType="pubmed">28973139</ArticleId><ArticleId IdType="pmc">5886083</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddx304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S et al (2021) C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci Adv. https://doi.org/10.1126/sciadv.abg3013</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pubmed">34272249</ArticleId><ArticleId IdType="pmc">8284894</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E et al (2013) Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol 12:978&#x2013;988</Citation><ArticleIdList><ArticleId IdType="pubmed">24011653</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(13)70210-2</ArticleId><ArticleId IdType="pmc">24011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennion Callister J, Ryan S, Sim J, Rollinson S, Pickering-Brown SM (2016) Modelling C9orf72 dipeptide repeat proteins of a physiologically relevant size. Hum Mol Genet 25:5069&#x2013;5082</Citation><ArticleIdList><ArticleId IdType="pubmed">27798094</ArticleId><ArticleId IdType="pmc">5886041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor&#xf3;n-Oset J, Sup&#xe8;r T, Esser J, Isaacs AM, Gr&#xf6;nke S, Partridge L (2019) Glycine-alanine dipeptide repeats spread rapidly in a repeat length- and age-dependent manner in the fly brain. Acta Neuropathol Commun 7:209</Citation><ArticleIdList><ArticleId IdType="pubmed">31843021</ArticleId><ArticleId IdType="pmc">6916080</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0860-x</ArticleId></ArticleIdList></Reference><Reference><Citation>West RJH, Sharpe JL, Voelzmann A et al (2020) Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age- and combination-specific phenotypic profiles in Drosophila. Acta Neuropathol Commun 8:158</Citation><ArticleIdList><ArticleId IdType="pubmed">32894207</ArticleId><ArticleId IdType="pmc">7487709</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01028-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Xu J (2018) C9orf72 dipeptide repeats cause selective neurodegeneration and cell-autonomous excitotoxicity in. J Neurosci 38:7741&#x2013;7752</Citation><ArticleIdList><ArticleId IdType="pubmed">30037833</ArticleId><ArticleId IdType="pmc">6705968</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.0908-18.2018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole study group. N Engl J Med 330:585&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pmc">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E et al (2016) Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep 6:20877</Citation><ArticleIdList><ArticleId IdType="pubmed">26869068</ArticleId><ArticleId IdType="pmc">4751451</ArticleId><ArticleId IdType="doi">10.1038/srep20877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR et al (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525:56&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">4800742</ArticleId><ArticleId IdType="pmc">4800742</ArticleId><ArticleId IdType="doi">10.1038/nature14973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham KM, Maulding K, Ruan K et al (2020) TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS. Elife. https://doi.org/10.7554/eLife.59419</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59419</ArticleId><ArticleId IdType="pubmed">33315009</ArticleId><ArticleId IdType="pmc">7806268</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Chung CG, Park SS et al (2020) Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin &#x3b1;3. Elife. https://doi.org/10.7554/eLife.60132</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60132</ArticleId><ArticleId IdType="pubmed">33331817</ArticleId><ArticleId IdType="pmc">7817186</ArticleId></ArticleIdList></Reference><Reference><Citation>Luty AA, Kwok JB, Dobson-Stone C et al (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68:639&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pubmed">21031579</ArticleId><ArticleId IdType="doi">10.1002/ana.22274</ArticleId><ArticleId IdType="pmc">21031579</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70:913&#x2013;919</Citation><ArticleIdList><ArticleId IdType="pubmed">21842496</ArticleId><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pmc">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, Epstein ML, Verbny YI et al (2013) Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 240:129&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">23458708</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2013.02.035</ArticleId><ArticleId IdType="pmc">23458708</ArticleId></ArticleIdList></Reference><Reference><Citation>Couly S, Khalil B, Viguier V, Roussel J, Maurice T, Li&#xe9;vens JC (2020) Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis. Hum Mol Genet 29:529&#x2013;540</Citation><ArticleIdList><ArticleId IdType="pubmed">31696229</ArticleId><ArticleId IdType="pmc">31696229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PT, Li&#xe9;vens JC, Wang SM et al (2020) Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nat Commun 11:5580</Citation><ArticleIdList><ArticleId IdType="pubmed">33149115</ArticleId><ArticleId IdType="pmc">7642387</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-19396-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega JA, Daley EL, Kour S et al (2020) Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron 106:90-107.e113</Citation><ArticleIdList><ArticleId IdType="pubmed">32059759</ArticleId><ArticleId IdType="pmc">7272217</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.01.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Bao P, Jiang X et al (2019) Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain 142:1349&#x2013;1364</Citation><ArticleIdList><ArticleId IdType="pubmed">30938419</ArticleId><ArticleId IdType="pmc">6487333</ArticleId><ArticleId IdType="doi">10.1093/brain/awz070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Eshov A, Zhou J, Isiktas AU, Guo JU (2020) C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression. Nat Commun 11:3354</Citation><ArticleIdList><ArticleId IdType="pubmed">32620797</ArticleId><ArticleId IdType="pmc">7335171</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-17129-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaepfel BL, Zhang Z, Maulding K et al (2021) UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction. Cell Rep. https://doi.org/10.1016/j.celrep.2021.108925</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108925</ArticleId><ArticleId IdType="pubmed">33789100</ArticleId><ArticleId IdType="pmc">8063722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel MW, Sen A, Lu L et al (2020) Amyotrophic lateral sclerosis modifiers in. Genetics 215:747&#x2013;766</Citation><ArticleIdList><ArticleId IdType="pubmed">32345615</ArticleId><ArticleId IdType="pmc">7337071</ArticleId><ArticleId IdType="doi">10.1534/genetics.119.302985</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Hentati A, Tainer JA et al (1993) Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261:1047&#x2013;1051</Citation><ArticleIdList><ArticleId IdType="pubmed">8351519</ArticleId><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pmc">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pmc">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 11:1603&#x2013;1614</Citation><ArticleIdList><ArticleId IdType="pubmed">19271992</ArticleId><ArticleId IdType="pmc">2842589</ArticleId><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard E, Pegat A, Svahn J et al (2020) Clinical and molecular landscape of ALS patients with. Int J Mol Sci. https://doi.org/10.3390/ijms21186807</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186807</ArticleId><ArticleId IdType="pubmed">32948071</ArticleId><ArticleId IdType="pmc">7554847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER (1996) A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci USA 93:5709&#x2013;5714</Citation><ArticleIdList><ArticleId IdType="pubmed">8650157</ArticleId><ArticleId IdType="pmc">39125</ArticleId><ArticleId IdType="doi">10.1073/pnas.93.12.5709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S et al (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851&#x2013;1854</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pmc">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockett RJ, Radyuk SN, Benes JJ, Orr WC, Sohal RS (2003) Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila. Proc Natl Acad Sci USA 100:301&#x2013;306</Citation><ArticleIdList><ArticleId IdType="pubmed">12502789</ArticleId><ArticleId IdType="doi">10.1073/pnas.0136976100</ArticleId><ArticleId IdType="pmc">12502789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187:761&#x2013;772</Citation><ArticleIdList><ArticleId IdType="pubmed">19951898</ArticleId><ArticleId IdType="pmc">2806318</ArticleId><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762:1051&#x2013;1067</Citation><ArticleIdList><ArticleId IdType="pubmed">16713195</ArticleId><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pmc">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia AJ, Parkes TL, Kirby K et al (1999) Expression of human FALS SOD in motorneurons of Drosophila. Free Radic Biol Med 26:1332&#x2013;1338</Citation><ArticleIdList><ArticleId IdType="pubmed">10381207</ArticleId><ArticleId IdType="doi">10.1016/S0891-5849(98)00333-5</ArticleId><ArticleId IdType="pmc">10381207</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson MR, Lagow RD, Xu K, Zhang B, Bonini NM (2008) A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem 283:24972&#x2013;24981</Citation><ArticleIdList><ArticleId IdType="pubmed">18596033</ArticleId><ArticleId IdType="pmc">2529125</ArticleId><ArticleId IdType="doi">10.1074/jbc.M804817200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahadorani S, Mukai ST, Rabie J, Beckman JS, Phillips JP, Hilliker AJ (2013) Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction. Neurobiol Aging 34:2322&#x2013;2330</Citation><ArticleIdList><ArticleId IdType="pubmed">23601674</ArticleId><ArticleId IdType="pmc">4145400</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.024</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rose F, Marotta R, Talani G et al (2017) Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS. Sci Rep 7:41059</Citation><ArticleIdList><ArticleId IdType="pubmed">28102336</ArticleId><ArticleId IdType="pmc">5244478</ArticleId><ArticleId IdType="doi">10.1038/srep41059</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni R, Setzu MD, Talani G et al (2018) Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS. Sci Rep 8:16002</Citation><ArticleIdList><ArticleId IdType="pubmed">30375462</ArticleId><ArticleId IdType="pmc">6207707</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-34452-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Yang Y, Liang W et al (2019) Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3&#x3b2;/Nrf2/GCLC pathways. Brain Res Bull 146:287&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pubmed">30690059</ArticleId><ArticleId IdType="doi">10.1016/j.brainresbull.2019.01.019</ArticleId><ArticleId IdType="pmc">30690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Cheng J, Wang S et al (2018) &#x3b1;-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis. Brain Res Bull 140:299&#x2013;310</Citation><ArticleIdList><ArticleId IdType="pubmed">29842900</ArticleId><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.019</ArticleId><ArticleId IdType="pmc">29842900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TH, Wang SY, Wang XD et al (2018) Fisetin exerts antioxidant and neuroprotective effects in multiple mutant hSOD1 models of amyotrophic lateral sclerosis by activating ERK. Neuroscience 379:152&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pubmed">29559385</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2018.03.008</ArticleId><ArticleId IdType="pmc">29559385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Liang W, Wang H et al (2019) &#x3b3;-Oryzanol mitigates oxidative stress and prevents mutant SOD1-related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2019.107777</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107777</ArticleId><ArticleId IdType="pubmed">31874170</ArticleId><ArticleId IdType="pmc">6745244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Lemay N, Ko HK et al (2010) Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19:4160&#x2013;4175</Citation><ArticleIdList><ArticleId IdType="pubmed">20699327</ArticleId><ArticleId IdType="pmc">2981014</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Zhang J, Kwinter DM et al (2011) Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 32:2323.e2327-2340</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.06.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, Krishnamurthy K, Ramesh N et al (2016) Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol 131:605&#x2013;620</Citation><ArticleIdList><ArticleId IdType="pubmed">26728149</ArticleId><ArticleId IdType="pmc">4791193</ArticleId><ArticleId IdType="doi">10.1007/s00401-015-1530-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Arai S, Song X et al (2008) Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454:126&#x2013;130</Citation><ArticleIdList><ArticleId IdType="pubmed">18509338</ArticleId><ArticleId IdType="pmc">2823488</ArticleId><ArticleId IdType="doi">10.1038/nature06992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Embree LJ, Tsai S, Hickstein DD (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273:27761&#x2013;27764</Citation><ArticleIdList><ArticleId IdType="pubmed">9774382</ArticleId><ArticleId IdType="doi">10.1074/jbc.273.43.27761</ArticleId><ArticleId IdType="pmc">9774382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory RI, Yan KP, Amuthan G et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">15531877</ArticleId><ArticleId IdType="doi">10.1038/nature03120</ArticleId><ArticleId IdType="pmc">15531877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan AY, Manley JL (2010) TLS inhibits RNA polymerase III transcription. Mol Cell Biol 30:186&#x2013;196</Citation><ArticleIdList><ArticleId IdType="pubmed">19841068</ArticleId><ArticleId IdType="doi">10.1128/MCB.00884-09</ArticleId><ArticleId IdType="pmc">19841068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR et al (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15:1488&#x2013;1497</Citation><ArticleIdList><ArticleId IdType="pubmed">23023293</ArticleId><ArticleId IdType="pmc">3586380</ArticleId><ArticleId IdType="doi">10.1038/nn.3230</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B, Easton LE, Bogu GK et al (2012) Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2:603</Citation><ArticleIdList><ArticleId IdType="pubmed">22934129</ArticleId><ArticleId IdType="pmc">3429604</ArticleId><ArticleId IdType="doi">10.1038/srep00603</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet MA, Jacques JF, Nassari S et al (2020) The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity. EMBO. https://doi.org/10.15252/embr.202050640</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202050640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205&#x2013;1208</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pmc">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208&#x2013;1211</Citation><ArticleIdList><ArticleId IdType="pubmed">4516382</ArticleId><ArticleId IdType="pmc">4516382</ArticleId><ArticleId IdType="doi">10.1126/science.1165942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang M, Deng J et al (2011) Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell 2:477&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pubmed">21748598</ArticleId><ArticleId IdType="pmc">3563268</ArticleId><ArticleId IdType="doi">10.1007/s13238-011-1065-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson NA, Pandey UB (2012) FUS-related proteinopathies: lessons from animal models. Brain Res 1462:44&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">22342159</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2012.01.039</ArticleId><ArticleId IdType="pmc">22342159</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidullah M, Le Marchand SJ, Fei H et al (2013) Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J Neurosci 33:19590&#x2013;19598</Citation><ArticleIdList><ArticleId IdType="pubmed">24336723</ArticleId><ArticleId IdType="pmc">3858628</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson NA, Maltare A, King H et al (2011) A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum Mol Genet 20:2510&#x2013;2523</Citation><ArticleIdList><ArticleId IdType="pubmed">21487023</ArticleId><ArticleId IdType="pmc">4288133</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD (2011) The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest 121:4118&#x2013;4126</Citation><ArticleIdList><ArticleId IdType="pubmed">21881207</ArticleId><ArticleId IdType="pmc">3195475</ArticleId><ArticleId IdType="doi">10.1172/JCI57883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R, Liu Y, Yang L, Gal J, Zhu H, Jia J (2012) Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol Neurodegener 7:10</Citation><ArticleIdList><ArticleId IdType="pubmed">22443542</ArticleId><ArticleId IdType="pmc">3325858</ArticleId><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L, Avequin T, Delarue M et al (2012) Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol Aging 33:1008.e1001-1015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J, Scheveneels W, Vanneste J et al (2018) FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum Mol Genet 27:4103&#x2013;4116</Citation><ArticleIdList><ArticleId IdType="pubmed">30379317</ArticleId><ArticleId IdType="pmc">6240733</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, Boeynaems S, Kato M et al (2018) Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep 24:529-537.e524</Citation><ArticleIdList><ArticleId IdType="pubmed">30021151</ArticleId><ArticleId IdType="pmc">6077250</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasayama H, Shimamura M, Tokuda T et al (2012) Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. PLoS ONE. https://doi.org/10.1371/journal.pone.0039483</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039483</ArticleId><ArticleId IdType="pubmed">22724023</ArticleId><ArticleId IdType="pmc">3378546</ArticleId></ArticleIdList></Reference><Reference><Citation>Frickenhaus M, Wagner M, Mallik M, Catinozzi M, Storkebaum E (2015) Highly efficient cell-type-specific gene inactivation reveals a key function for the Drosophila FUS homolog cabeza in neurons. Sci Rep 5:9107</Citation><ArticleIdList><ArticleId IdType="pubmed">25772687</ArticleId><ArticleId IdType="pmc">5390904</ArticleId><ArticleId IdType="doi">10.1038/srep09107</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M et al (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68:857&#x2013;864</Citation><ArticleIdList><ArticleId IdType="pubmed">21145000</ArticleId><ArticleId IdType="pmc">3032425</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y, Tokuda T, Shimamura M et al (2014) Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Hum Mol Genet 23:3467&#x2013;3480</Citation><ArticleIdList><ArticleId IdType="pubmed">24497576</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddu055</ArticleId><ArticleId IdType="pmc">24497576</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley J, Hagemann C, Serio A, Patani R (2020) FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS. Brain. https://doi.org/10.1093/brain/awaa339</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa339</ArticleId><ArticleId IdType="pubmed">33253377</ArticleId><ArticleId IdType="pmc">7805784</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Krishnamurthy K, Kour S et al (2019) Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nat Commun 10:5583</Citation><ArticleIdList><ArticleId IdType="pubmed">31811140</ArticleId><ArticleId IdType="pmc">6898697</ArticleId><ArticleId IdType="doi">10.1038/s41467-019-13383-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanadia RN, Johnstone KA, Mankodi A et al (2003) A muscleblind knockout model for myotonic dystrophy. Science 302:1978&#x2013;1980</Citation><ArticleIdList><ArticleId IdType="pubmed">14671308</ArticleId><ArticleId IdType="doi">10.1126/science.1088583</ArticleId><ArticleId IdType="pmc">14671308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicki DD, Holmes SE, Lin MW, Thornton CA, Ross CA, Margolis RL (2007) Huntington&#x2019;s disease&#x2013;like 2 is associated with CUG repeat-containing RNA foci. Ann Neurol 61:272&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">17387722</ArticleId><ArticleId IdType="doi">10.1002/ana.21081</ArticleId><ArticleId IdType="pmc">17387722</ArticleId></ArticleIdList></Reference><Reference><Citation>Daughters RS, Tuttle DL, Gao W et al (2009) RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. https://doi.org/10.1371/journal.pgen.1000600</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000600</ArticleId><ArticleId IdType="pubmed">19680539</ArticleId><ArticleId IdType="pmc">2719092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Rau F, Liu Y et al (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 29:1248&#x2013;1261</Citation><ArticleIdList><ArticleId IdType="pubmed">20186122</ArticleId><ArticleId IdType="pmc">2857464</ArticleId><ArticleId IdType="doi">10.1038/emboj.2010.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardenne E, Polay Espinoza M, Fattet L et al (2014) RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep 7:1900&#x2013;1913</Citation><ArticleIdList><ArticleId IdType="pubmed">24910439</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2014.05.010</ArticleId><ArticleId IdType="pmc">24910439</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraud G, Terrone S, Bourgeois CF (2018) Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation. BMB Rep 51:613&#x2013;622</Citation><ArticleIdList><ArticleId IdType="pubmed">30293550</ArticleId><ArticleId IdType="pmc">6330936</ArticleId><ArticleId IdType="doi">10.5483/BMBRep.2018.51.12.234</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortuna TR, Kour S, Anderson EN et al (2021) DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner. Acta Neuropathol. https://doi.org/10.1007/s00401-021-02333-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02333-z</ArticleId><ArticleId IdType="pubmed">34061233</ArticleId><ArticleId IdType="pmc">34061233</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Khalil B, Smith CL, Rossoll W (2020) Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2020.104835</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId><ArticleId IdType="pmc">7253339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Kumar MS, Ramesh N et al (2021) Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat Neurosci. https://doi.org/10.1038/s41593-021-00859-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId><ArticleId IdType="pmc">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y, Hata Y, Ikeda M, Withanage K (2011) Mammalian Hippo pathway: from development to cancer and beyond. J Biochem 149:361&#x2013;379</Citation><ArticleIdList><ArticleId IdType="pubmed">21324984</ArticleId><ArticleId IdType="doi">10.1093/jb/mvr021</ArticleId><ArticleId IdType="pmc">21324984</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y, Tokuda T, Kushimura Y et al (2018) Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp Cell Res 371:311&#x2013;321</Citation><ArticleIdList><ArticleId IdType="pubmed">30092221</ArticleId><ArticleId IdType="doi">10.1016/j.yexcr.2018.08.001</ArticleId><ArticleId IdType="pmc">30092221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia N, Sarkar A, Mehta AS et al (2020) Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2020.104837</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104837</ArticleId><ArticleId IdType="pubmed">32199908</ArticleId><ArticleId IdType="pmc">32199908</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha SJ, Choi HJ, Kim HJ et al (2020) Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis. Insect Mol Biol 29:56&#x2013;65</Citation><ArticleIdList><ArticleId IdType="pubmed">31290213</ArticleId><ArticleId IdType="doi">10.1111/imb.12608</ArticleId><ArticleId IdType="pmc">31290213</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ (2009) Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 1305:168&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pubmed">19815002</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pmc">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 7:420&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">20639693</ArticleId><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pmc">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276:36337&#x2013;36343</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pmc">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pmc">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45</Citation><ArticleIdList><ArticleId IdType="pubmed">32799899</ArticleId><ArticleId IdType="pmc">7429473</ArticleId><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW (2017) Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet 136:1193&#x2013;1214</Citation><ArticleIdList><ArticleId IdType="pubmed">28762175</ArticleId><ArticleId IdType="pmc">5602095</ArticleId><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson KA, Kim SH, Wassarman DA, Tibbetts RS (2010) Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J Biol Chem 285:11068&#x2013;11072</Citation><ArticleIdList><ArticleId IdType="pubmed">20154090</ArticleId><ArticleId IdType="pmc">2856981</ArticleId><ArticleId IdType="doi">10.1074/jbc.C109.078527</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ray P, Rao EJ et al (2010) A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci USA 107:3169&#x2013;3174</Citation><ArticleIdList><ArticleId IdType="pubmed">20133767</ArticleId><ArticleId IdType="pmc">2840283</ArticleId><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A, Herholz D, Fiesel FC et al (2010) TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE. https://doi.org/10.1371/journal.pone.0012247</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pubmed">20967213</ArticleId><ArticleId IdType="pmc">2954171</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC (2011) Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 20:2308&#x2013;2321</Citation><ArticleIdList><ArticleId IdType="pubmed">21441568</ArticleId><ArticleId IdType="pmc">3098735</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L, Fr&#xe9;bourg T, Campion D, Lecourtois M (2011) Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiol Dis 41:398&#x2013;406</Citation><ArticleIdList><ArticleId IdType="pubmed">20951205</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2010.10.007</ArticleId><ArticleId IdType="pmc">20951205</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Daniel SG, McCallum AP et al (2013) Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis Model Mech 6:721&#x2013;733</Citation><ArticleIdList><ArticleId IdType="pubmed">23471911</ArticleId><ArticleId IdType="pmc">3634655</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L, Chatterjee N, Borges-Monroy R et al (2017) Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. https://doi.org/10.1371/journal.pgen.1006635</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId><ArticleId IdType="pmc">5354250</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MJ, Cheng CW, Shen CK (2011) Neuronal function and dysfunction of Drosophila dTDP. PLoS ONE. https://doi.org/10.1371/journal.pone.0020371</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pubmed">22242118</ArticleId><ArticleId IdType="pmc">3248434</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper DC, Adachi Y, Lazarou L et al (2013) Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet 22:3883&#x2013;3893</Citation><ArticleIdList><ArticleId IdType="pubmed">23727833</ArticleId><ArticleId IdType="pmc">3766182</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddt243</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F, Godena VK, Romano G, D&#x2019;Ambrogio A, Klima R, Baralle FE (2009) Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett 583:1586&#x2013;1592</Citation><ArticleIdList><ArticleId IdType="pubmed">19379745</ArticleId><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pmc">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HY, Wang IF, Bose J, Shen CK (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83:130&#x2013;139</Citation><ArticleIdList><ArticleId IdType="pubmed">14667816</ArticleId><ArticleId IdType="doi">10.1016/S0888-7543(03)00214-3</ArticleId><ArticleId IdType="pmc">14667816</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pmc">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G, Klima R, Buratti E, Verstreken P, Baralle FE, Feiguin F (2014) Chronological requirements of TDP-43 function in synaptic organization and locomotive control. Neurobiol Dis 71:95&#x2013;109</Citation><ArticleIdList><ArticleId IdType="pubmed">25088713</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2014.07.007</ArticleId><ArticleId IdType="pmc">25088713</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G, Appocher C, Scorzeto M et al (2015) Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms. Hum Mol Genet 24:6134&#x2013;6145</Citation><ArticleIdList><ArticleId IdType="pubmed">26276811</ArticleId><ArticleId IdType="pmc">4599672</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddv330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Shanware NP, Bowler MJ, Tibbetts RS (2010) Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 285:34097&#x2013;34105</Citation><ArticleIdList><ArticleId IdType="pubmed">20720006</ArticleId><ArticleId IdType="pmc">2962508</ArticleId><ArticleId IdType="doi">10.1074/jbc.M110.154831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Albuquerque CP, Han JS et al (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 107:13318&#x2013;13323</Citation><ArticleIdList><ArticleId IdType="pubmed">20624952</ArticleId><ArticleId IdType="pmc">2922163</ArticleId><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Fleming A, Caricasole A et al (2017) Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93:1015&#x2013;1034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CW, Lin MJ, Shen CK (2015) Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J Neurogenet 29:59&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">26219309</ArticleId><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pmc">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A, Sun M, Jeong YH et al (2020) Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP/TDP-43. Autophagy 16:672&#x2013;682</Citation><ArticleIdList><ArticleId IdType="pubmed">31242080</ArticleId><ArticleId IdType="doi">10.1080/15548627.2019.1635379</ArticleId><ArticleId IdType="pmc">31242080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Pesaresi MG, Amori I et al (2009) Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid Redox Signal 11:1547&#x2013;1558</Citation><ArticleIdList><ArticleId IdType="pubmed">19344252</ArticleId><ArticleId IdType="doi">10.1089/ars.2009.2545</ArticleId><ArticleId IdType="pmc">19344252</ArticleId></ArticleIdList></Reference><Reference><Citation>Tradewell ML, Yu Z, Tibshirani M, Boulanger MC, Durham HD, Richard S (2012) Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Hum Mol Genet 21:136&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">21965298</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddr448</ArticleId><ArticleId IdType="pmc">21965298</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, Colombrita C, Gumina V et al (2016) Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun 4:47</Citation><ArticleIdList><ArticleId IdType="pubmed">27151080</ArticleId><ArticleId IdType="pmc">4858818</ArticleId><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B, Cabirol-Pol MJ, Miguel L, Whitworth AJ, Lecourtois M, Li&#xe9;vens JC (2017) Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. Neurobiol Aging 54:71&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">28324764</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.02.016</ArticleId><ArticleId IdType="pmc">28324764</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Duan Y, Qin C et al (2018) Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis 9:953</Citation><ArticleIdList><ArticleId IdType="pubmed">30237395</ArticleId><ArticleId IdType="pmc">6148241</ArticleId><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Siddegowda BB, Estes PS et al (2014) Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci 34:15962&#x2013;15974</Citation><ArticleIdList><ArticleId IdType="pubmed">25429138</ArticleId><ArticleId IdType="pmc">4244467</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazelett DJ, Chang JC, Lakeland DL, Morton DB (2012) Comparison of parallel high-throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. G3 (Bethesda). https://doi.org/10.1534/g3.112.002998</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.112.002998</ArticleId><ArticleId IdType="pmc">3385985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC, Hazelett DJ, Stewart JA, Morton DB (2014) Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. Brain Res 1584:39&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">24275199</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2013.11.019</ArticleId><ArticleId IdType="pmc">24275199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R, Matsukawa K, Nagata Y et al (2013) RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum Mol Genet 22:4474&#x2013;4484</Citation><ArticleIdList><ArticleId IdType="pubmed">23804749</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddt296</ArticleId><ArticleId IdType="pmc">23804749</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L, Felemban R, Scott DD et al (2019) Small molecule targeting TDP-43&#x2019;s RNA recognition motifs reduces locomotor defects in a. ACS Chem Biol 14:2006&#x2013;2013</Citation><ArticleIdList><ArticleId IdType="pubmed">31241884</ArticleId><ArticleId IdType="pmc">6911355</ArticleId><ArticleId IdType="doi">10.1021/acschembio.9b00481</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A, Goodman LD, Sartoris AN et al (2019) Drosophila Ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies. Acta Neuropathol Commun 7:65</Citation><ArticleIdList><ArticleId IdType="pubmed">31036086</ArticleId><ArticleId IdType="pmc">6487524</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0710-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Torny F, Lacoste M, Preux PM, Couratier P (2005) Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2:202&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">16909026</ArticleId><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pmc">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A et al (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004&#x2013;1009</Citation><ArticleIdList><ArticleId IdType="pubmed">18199832</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pmc">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A, Manzo E, Zarnescu DC (2017) Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities. Curr Genet Med Rep 5:108&#x2013;114</Citation><ArticleIdList><ArticleId IdType="pubmed">29057168</ArticleId><ArticleId IdType="pmc">5647833</ArticleId><ArticleId IdType="doi">10.1007/s40142-017-0123-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, O&#x2019;Conner AG, Barrows JM, Shreiner DD, Birchak GJ, Zarnescu DC (2018) Medium-chain fatty acids, beta-hydroxybutyric acid and genetic modulation of the carnitine shuttle are protective in a Drosophila model of ALS based on TDP-43. Front Mol Neurosci 11:182</Citation><ArticleIdList><ArticleId IdType="pubmed">29904341</ArticleId><ArticleId IdType="pmc">5990617</ArticleId><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, Lorenzini I, Barrameda D et al (2019) Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife. https://doi.org/10.7554/eLife.45114</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId><ArticleId IdType="pmc">6557627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst SM, Nechiporuk A, Nechiporuk T et al (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14:269&#x2013;276</Citation><ArticleIdList><ArticleId IdType="pubmed">8896555</ArticleId><ArticleId IdType="doi">10.1038/ng1196-269</ArticleId><ArticleId IdType="pmc">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanpei K, Takano H, Igarashi S et al (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14:277&#x2013;284</Citation><ArticleIdList><ArticleId IdType="pubmed">8896556</ArticleId><ArticleId IdType="doi">10.1038/ng1196-277</ArticleId><ArticleId IdType="pmc">8896556</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield TF, Jackson SM, Pallanck LJ (2002) A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics 162:1687&#x2013;1702</Citation><ArticleIdList><ArticleId IdType="pubmed">12524342</ArticleId><ArticleId IdType="pmc">1462369</ArticleId><ArticleId IdType="doi">10.1093/genetics/162.4.1687</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhoff U, Ralser M, Welzel F et al (2007) Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 18:1385&#x2013;1396</Citation><ArticleIdList><ArticleId IdType="pubmed">17392519</ArticleId><ArticleId IdType="pmc">1838996</ArticleId><ArticleId IdType="doi">10.1091/mbc.e06-12-1120</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ (2014) Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends Mol Med 20:25&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">24140266</ArticleId><ArticleId IdType="doi">10.1016/j.molmed.2013.09.001</ArticleId><ArticleId IdType="pmc">24140266</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069&#x2013;1075</Citation><ArticleIdList><ArticleId IdType="pubmed">20740007</ArticleId><ArticleId IdType="pmc">2965417</ArticleId><ArticleId IdType="doi">10.1038/nature09320</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthavachalu B, Huelsmeier J, Sudhakaran IP et al (2018) RNP-granule assembly via ataxin-2 disordered domains is required for long-term memory and neurodegeneration. Neuron 98:754-766.e754</Citation><ArticleIdList><ArticleId IdType="pubmed">29772202</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2018.04.032</ArticleId><ArticleId IdType="pmc">29772202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Raphael AR, LaDow ES et al (2014) Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet 46:152&#x2013;160</Citation><ArticleIdList><ArticleId IdType="pubmed">24336168</ArticleId><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield TF, Pallanck LJ (2006) Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet 15:2523&#x2013;2532</Citation><ArticleIdList><ArticleId IdType="pubmed">16835262</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddl173</ArticleId><ArticleId IdType="pmc">16835262</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Alexeeva OM, Yamada S et al (2015) PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum Mol Genet 24:5154&#x2013;5173</Citation><ArticleIdList><ArticleId IdType="pubmed">26130692</ArticleId><ArticleId IdType="pmc">4550816</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddv238</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L et al (2018) Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol Cell 71:703-717.e709</Citation><ArticleIdList><ArticleId IdType="pubmed">30100264</ArticleId><ArticleId IdType="pmc">6128762</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Du A, Gu J et al (2019) PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res 29:233&#x2013;247</Citation><ArticleIdList><ArticleId IdType="pubmed">30728452</ArticleId><ArticleId IdType="pmc">6460439</ArticleId><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>